Taro-Dipyridamole/ASA · DIN 02471051 · 200 mg/25 mg · capsule
Limited Use, Reason for Use code 349 required; Health Canada lists this DIN as Cancelled post market since 2024-07-31 — choose a marketed DIN from the same-category list.Discontinued July 31, 2024 · checked November 20, 2026
StatusLimited Use, Reason for Use code 349 required; Health Canada lists this DIN as Cancelled post market since 2024-07-31 — choose a marketed DIN from the same-category list.
Write on scriptReason for Use code 349 (criteria below); Health Canada lists this DIN as Cancelled post market since 2024-07-31 — choose a marketed DIN from the same-category list.
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 349
Reason for Use code 349
For the secondary prevention of stroke.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Taro-Dipyridamole/ASA · DIN 02471051
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2019-01-31
Health Canada: Cancelled post market since 2024-07-31 · brand TARO-DIPYRIDAMOLE/ ASA · ATC B01AC30 COMBINATIONS · form Capsule (immediate- and extended-release · route Oral · ingredients DIPYRIDAMOLE 200 MG, ACETYLSALICYLIC ACID 25 MG · company Taro pharmaceuticals inc · schedule Prescription
Taro-Dipyridamole/ASA: Formulary list price $0.67 per unit (the source does not state the unit; exact figure $0.6656). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02471051)
Source record
DIN 02471051: Taro-Dipyridamole/ASA
Raw flags: sec12=Y, sec3=Y
Item: 241200078; group id 365; item number 0854; lccId 00062; manufacturer id TAR
Source form: Cap; strength: 200mg/25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.6656; ministry $0.6656
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02471051
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96015
Interchangeable products
Aggrenox · DIN 02242119 · not recorded
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since July 31, 2024 — choose a marketed DIN from the same-category list.